US Site 1 — Wyomissing, Pennsylvania

US Site 1 is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

US Site 1 has participated in 1 clinical trials.

Therapeutic areas: Hypertriglyceridemia, Type 2 Diabetes.

Sponsors: Afimmune.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Site 1?

US Site 1 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Site 1 conducted?

US Site 1 has 1 clinical trials on record. Their work covers Hypertriglyceridemia, Type 2 Diabetes.

Is US Site 1 accredited by Crixeo Health?

US Site 1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Site 1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.